Remarkable effect of milnacipran, a serotonin–noradrenalin reuptake inhibitor (SNRI), on depressive symptoms in patients with Parkinson's disease who have insufficient response to selective serotonin reuptake inhibitors (SSRIs): two case reports

✍ Scribed by Hitoshi Takahashi; Mitsuhiro Kamata; Keizo Yoshida; Hisashi Higuchi; Tetsuo Shimizu

• Book ID: 116840465
• Publisher: Elsevier Science
• Year: 2005
• Tongue: English
• Weight: 70 KB
• Volume: 29
• Category: Article
• ISSN: 0278-5846
• DOI: 10.1016/j.pnpbp.2004.11.023